Taken together, this data suggested that BCL-XL is the most consistently upregulated BCL-2 family member in SCCHN, although targeting BCL-XL alone did not result in enhanced apoptosis in SCCHN cell lines (Fig. 1c). Here, BCL2L1 is linked to head and neck squamous cell carcinoma.